Susquehanna International Group
OLMA icon

Susquehanna International Group’s Olema Pharmaceuticals OLMA Stock Holding History

Susquehanna International Group’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.26M Buy
285,882
+274,658
+2,447% +$6.11M ﹤0.01% 4536
2025
Q4 		$281K Sell
11,224
-101,053
-90% -$1.8M ﹤0.01% 10099
2025
Q3 		$1.1M Buy
112,277
+19,182
+21% +$115K ﹤0.01% 7125
2025
Q2 		$397K Buy
93,095
+21,307
+30% +$95K ﹤0.01% 9713
2025
Q1 		$270K Buy
71,788
+5,568
+8% +$28K ﹤0.01% 10290
2024
Q4 		$386K Buy
66,220
+19,952
+43% +$199K ﹤0.01% 9287
2024
Q3 		$552K Sell
46,268
-19,870
-30% -$254K ﹤0.01% 8220
2024
Q2 		$716K Buy
66,138
+18,102
+38% +$196K ﹤0.01% 7360
2024
Q1 		$544K Sell
48,036
-103,831
-68% -$1.34M ﹤0.01% 8304
2023
Q4 		$2.13M Buy
151,867
+116,874
+334% +$1.57M ﹤0.01% 5210
2023
Q3 		$432K Buy
34,993
+24,921
+247% +$254K ﹤0.01% 8573
2023
Q2 		$91K Sell
10,072
-77,944
-89% -$471K ﹤0.01% 11018
2023
Q1 		$305K Buy
+88,016
New +$359K ﹤0.01% 9683
2022
Q4 		– Sell
-12,622
Closed -$36.8K – 13309
2022
Q3 		$35K Sell
12,622
-14,548
-54% -$61.7K ﹤0.01% 12397
2022
Q2 		$111K Sell
27,170
-14,251
-34% -$45.2K ﹤0.01% 11380
2022
Q1 		$176K Sell
41,421
-249,833
-86% -$1.38M ﹤0.01% 11391
2021
Q4 		$2.73M Buy
+291,254
New +$6.03M ﹤0.01% 4823
2021
Q2 		– Sell
-43,254
Closed -$1.44M – 13044
2021
Q1 		$1.44M Buy
43,254
+155
+0.4% +$6.64K ﹤0.01% 6768
2020
Q4 		$2.07M Buy
+43,099
New +$2.02M ﹤0.01% 5019

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Susquehanna International Group's OLMA Position: Q1 2026 in Review

Susquehanna International Group increased its Olema Pharmaceuticals (OLMA) stake by 2,447% in Q1 2026, buying an estimated $6.11M and bringing the position to 285,882 shares worth $4.26M. The position accounts for ﹤0.01% of the portfolio, ranked #4536.

Susquehanna International Group first reported a position in OLMA in Q4 2020 and has held it in 19 quarters since. 195 funds tracked by Wall St. Rank hold OLMA as of Q1 2026.

  • Susquehanna International Group held 285,882 shares of Olema Pharmaceuticals worth $4.26M as of Q1 2026.
  • Susquehanna International Group bought 274,658 Olema Pharmaceuticals shares in Q1 2026, an estimated $6.11M.
  • Olema Pharmaceuticals made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #4536 holding.
  • Susquehanna International Group first reported a position in Olema Pharmaceuticals in Q4 2020 and has held it in 19 quarters since.
  • 195 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.